跳至主要内容
临床试验/NCT01521286
NCT01521286已完成不适用

Population Based Surveillance to Estimate the Burden of Herpes Zoster and Postherpetic Neuralgia in Spain

GlaxoSmithKline1 个研究点 分布在 1 个国家目标入组 552 人开始时间: 2012年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
552
试验地点
1
主要终点
Total number of HZ cases as recorded per participating practice, overall and within a specific age group and gender.

研究概览

简要总结

The purpose of this study is to collect data on the incidence, complications and impact on quality of life of herpes zoster (HZ) disease in adults >=50 years of age in Spain. This study will also collect data on costs related to the HZ disease, especially postherpetic neuralgia (PHN)

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • A male or female >=50 years of age at the time of study enrolment presenting with acute HZ;
  • HZ diagnosis for this HZ episode;
  • is the subject's first outpatient diagnosis; OR
  • took place at another site/ centre up to seven days before the initial visit for the present study;
  • Ability to comply with study procedures*;
  • Written informed consent obtained from the subject*. Note: * will be applicable to secondary objectives only and not for the primary objective to calculate incidence.

排除标准

  • Subject participating in another research study. Note: This exclusion criteria is applicable to secondary objectives only and not for the primary objectives to calculate incidence.

结局指标

主要结局

Total number of HZ cases as recorded per participating practice, overall and within a specific age group and gender.

时间窗: up to one year

次要结局

  • Occurrence of PHN, i.e. persistence of HZ-related pain.(90, 180, and 270 days after onset of HZ.)
  • Anamnestic information, clinical parameters and complications related to HZ.(Between Day 0 and Day 270)
  • Direct medical, direct non-medical and indirect costs related to HZ.(Between Day 0 and Day 90)
  • Pain assessment in HZ subjects.(At Day 90)
  • Quality of life assessment in HZ subjects(Day 15, Day 30, Day 60 and Day 90)
  • Direct medical, direct non-medical and indirect costs related to PHN.(At Day 90, Day 180 and Day 270)
  • Pain assessment in PHN subjects.(At Day 90, Day 180 and Day 270)
  • Quality of life assessment in PHN subjects.(At Day 90, Day 180 and Day 270)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Study to Estimate the Burden of Herpes Zoster and... | 临床试验